Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Lifestyle Intervention for MCI in Older Chinese Adults
NCT02409238Phase 4Terminated
- Sponsor
- SingHealth Polyclinics
- Start
- Mar 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in Mild Cognitive Impairment (MCI), sponsored by SingHealth Polyclinics. Started Mar 2015; status: terminated.
02
Drugs
metformin
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT02409238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02409238.